WPRIM Management System> DCMS> Chinese Journal of Blood Transfusion> 2026> 39> 3

Volume: 39 Issue: 3

1. Whole-genome sequencing analysis of co-existing bacteria in platelet products: genomic features and biological implications Page:305—316
2. Construction of gene recombinant IgG1 κ anti-P plasmids and their expression in HEK293T Cells Page:317—322
3. Effect of leukocyte-reduced platelet transfusion on the production of HLA antibodies in patients Page:323—328
4. A survey of transfusion medicine knowledge among pediatricians/postgraduates and an evaluation of large language models for learning assistance Page:329—338
5. Analysis of the current situation and influencing factors of platelet supply in medical institutions Page:339—345
6. A retrospective cohort analysis on the association between blood donation intervals and adverse reactions to blood donation in Shenzhen, China Page:346—352
7. A retrospective cohort analysis on the association between blood donor age and adverse reactions to blood donation in Shenzhen Page:353—359
8. Epidemiological characteristics, outcome analysis, and management strategies for DAT-positive blood donors Page:360—366
9. Study on the correlation between HLA antibodies and pregnancy-related factors, and the predictive value of a random-forest model among female blood donors in Nanning Page:367—372
10. Analysis of hepatitis B infection characteristics in HBsAg-/HBV DNA+ blood donors in Taiyuan Page:373—378
11. Evaluation of the application effectiveness and optimization strategies of confidential unit exclusion in Zhengzhou Page:379—383
12. Quality assessment of blood components prepared by an automatic whole blood processing system Page:384—390
13. A real-time process monitoring scheme for blood center NAT using the median of internal control CT value Page:391—396
14. Red blood cell transfusion refractoriness due to mimicking alloantibodies: a case report Page:397—401
15. Advances in detection techniques for congenital blood group chimerism Page:402—407
16. The introduction and implications of the European Blood Alliance practical guidance on implementation of a whole blood programme within a blood service Page:408—412